<DOC>
	<DOC>NCT02885987</DOC>
	<brief_summary>The purpose of this investigator-initiated study is to determine whether the use of an accessory device called AmplifEYE can improve colonoscopy quality in patients who are undergoing average risk colorectal cancer screening. Primary end point is adenoma detection rates.</brief_summary>
	<brief_title>Use of Accessory Device AmplifEYE During Average Risk Screening Colonoscopy to Increase Adenoma Detection Rate</brief_title>
	<detailed_description />
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Colonic Polyps</mesh_term>
	<criteria>All adult patients greater than or at 50 years of age who are referred for average risk screening colonoscopy. Any pregnant patient Patient's that are unable to provide consent for themselves Any patient undergoing diagnostic colonoscopy (IBD, rectal bleeding, recent change in bowel habits, etc.) Any patient undergoing surveillance (prior history of polyps or colorectal cancer) Any patient undergoing high risk screening colonoscopy (family history of colon cancer in first degree family member &lt;65 years of age, or coexisting conditions that predispose to colon cancer such as polyposis syndromes, PSC or IBD) Prior history of any cancer Current or past immunosuppression (due to either infection or medications) Coagulation disorder OR use of anticoagulation or antiplatelet therapy other than aspirin within 57 days of procedure Colonic strictures suspected intestinal obstruction or colonic pseudoobstruction history of colon resection active infection active inflammation (including diverticulitis)</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>